基于纳米乳液配方工艺的新型水凝:开发,风病学特征和作为药物输送系统的研究
Usama Jamshaid1,2, Nicolas Anton1, Mohamed Elhassan1,3
1INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS, Université de Strasbourg, F-67000 Strasbourg, France.
Pharmaceutics
|June 27, 2024
概括
研究人员开发了新的无聚合物纳米乳,仅使用非离子表面活性剂,油和水. 这些有前途的系统提供了一个简单的单步配方,用于封装和输送各种分子.
科学领域:
- 材料科学 材料科学 材料科学
- 合体和表面化学
背景情况:
- 传统的水凝通常依赖于聚合物,这可能会使配方和生物相容性复杂化.
- 基于乳液的凝配方通常涉及复杂的,多步骤的过程.
研究的目的:
- 引入一种由非离子表面活性剂,油和水制成的新型无聚合物水凝系统 (纳米乳).
- 研究这些纳米乳液的形成,特性和潜在应用,用于分子封装和输送.
主要方法:
- 采用一种灵感来自自发乳化过程的简单,一步制剂.
- 采用振荡性风湿学表征来研究凝形成,sol/gel过渡和凝强度.
- 监测一个封装水友模型分子的释放特征.
主要成果:
- 从非离子表面活性剂,油和水中成功形成无聚合物水凝 (纳米乳液).
- 描述了凝过程,证明了对sol/gel过渡和凝强度的控制.
- 研究了水友性分子的封装和释放,将释放特征与风湿性质相关联.
结论:
- 开发的纳米乳液代表了一种新且有前途的无聚合物水凝类型.
- 简单的一步制剂过程在传统方法上提供了优势.
- 这些系统展示了封装和输送具有不同溶解度的分子的潜力,释放受到凝性质的影响.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
135
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
135
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
169
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
169